药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Rabies virus inactivated antigen, B
The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
TG4010
The therapeutic efficacy of TG4010 can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Vitespen
The therapeutic efficacy of Vitespen can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
GI-5005
The therapeutic efficacy of GI-5005 can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
SRP 299
The therapeutic efficacy of SRP 299 can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Acetyldigoxin
The risk or severity of adverse effects can be increased when Prednisolone acetate is combined with Acetyldigoxin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Gitoformate
The risk or severity of adverse effects can be increased when Prednisolone acetate is combined with Gitoformate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Lanatoside C
The risk or severity of adverse effects can be increased when Prednisolone acetate is combined with Lanatoside C.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Metildigoxin
The risk or severity of adverse effects can be increased when Prednisolone acetate is combined with Metildigoxin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Gastric inhibitory polypeptide
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Gastric inhibitory polypeptide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Tirzepatide
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Tirzepatide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Englitazone
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Englitazone.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Taspoglutide
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Taspoglutide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Semaglutide
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Semaglutide.